These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9543579)

  • 1. Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment.
    García-Porrúa C; González-Gay MA; Fernández-Lamelo F; Paz-Carreira JM; Lavilla E; González-López MA
    Clin Exp Rheumatol; 1998; 16(1):107-8. PubMed ID: 9543579
    [No Abstract]   [Full Text] [Related]  

  • 2. 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.
    Mehta ND; Hooberman AL; Vokes EE; Neeley S; Cotler S
    Am J Hematol; 1992 Oct; 41(2):141. PubMed ID: 1415177
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus following interferon therapy.
    Flores A; Olivé A; Feliu E; Tena X
    Br J Rheumatol; 1994 Aug; 33(8):787. PubMed ID: 8055211
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune-mediated complications during interferon alpha therapy in chronic myelogenous leukemia.
    Tóthová E; Kafková A; Stecová N; Fricová M; Guman T; Svorcová E
    Neoplasma; 2002; 49(2):91-4. PubMed ID: 12088112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
    Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
    Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune hemolytic anemia during alpha-interferon treatment in a patient with chronic myelogenous leukemia.
    Stavroyianni N; Stamatopoulos K; Viniou N; Vaiopoulos G; Yataganas X
    Leuk Res; 2001 Dec; 25(12):1097-8. PubMed ID: 11684283
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.
    Schilling PJ; Kurzrock R; Kantarjian H; Gutterman JU; Talpaz M
    Cancer; 1991 Oct; 68(7):1536-7. PubMed ID: 1893353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.
    Arimura K; Arima N; Ohtsubo H; Matsushita K; Kukita T; Ayukawa T; Kuroki T; Tei C
    Acta Haematol; 2004; 112(4):217-8. PubMed ID: 15564735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microangiopathy in patients with chronic myelogenous leukemia treated with interferon.
    Creutzig A; Freund M; Caspary L; Alexander K
    Microvasc Res; 1996 Nov; 52(3):288-92. PubMed ID: 8954870
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes.
    Ariad S; Song E; Cohen R; Bezwoda WR
    Mol Biother; 1992 Sep; 4(3):139-42. PubMed ID: 1445668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of chorea with lupus anticoagulant after interferon therapy.
    Neau JP; Guilhot F; Boinot C; Dumas P; Tantot AM; Gil R
    Eur Neurol; 1996; 36(4):235-6. PubMed ID: 8814429
    [No Abstract]   [Full Text] [Related]  

  • 12. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
    Ladoyanni E; Nambi R
    J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
    Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe intravascular hemolysis associated with interferon treatment for chronic myeloid leukemia.
    Tuckfield A; Metz J; Grigg A
    Am J Hematol; 1996 Sep; 53(1):52-3. PubMed ID: 8813104
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
    Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
    Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
    Schlaifer D; Dumazer P; Spenatto N; Mignon-Conte M; Brousset P; Lumbroso C; Cooper M; Muller C; Huguet F; Attal M
    Am J Hematol; 1994 Nov; 47(3):254-5. PubMed ID: 7942805
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy.
    Zheng WL; Zhang GS; Shen JK; Pei MF; Peng HL; Xu M
    Thromb Res; 2011 Aug; 128(2):202-3. PubMed ID: 21621826
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of Systemic Lupus Erythematosus Following Interferon-α Therapy for Hepatitis C Infection.
    Khalil-Ur-Rehman ; Khokhar N
    J Coll Physicians Surg Pak; 2016 Mar; 26(3):223-4. PubMed ID: 26975957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute thyroiditis associated with interferon-alpha 2a therapy.
    González-Fernández B; Arranz A; Peñarrubia MJ; Marazuela M
    Horm Metab Res; 1995 Jan; 27(1):45-6. PubMed ID: 7729795
    [No Abstract]   [Full Text] [Related]  

  • 20. Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia.
    Yufu Y; Yamashita S; Nishimura J; Nawata H; Hirata J
    Am J Hematol; 1994 Nov; 47(3):253. PubMed ID: 7942803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.